Bowen–Conradi syndrome
| Bowen–Conradi syndrome | |
|---|---|
| Synonyms | Bowen–Conradi syndrome |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Failure to thrive, microcephaly, micrognathia, clinodactyly, rocker-bottom feet, cryptorchidism |
| Complications | N/A |
| Onset | Congenital |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutation in the EMG1 gene |
| Risks | Autosomal recessive inheritance, higher prevalence in Hutterite populations |
| Diagnosis | Genetic testing, clinical evaluation |
| Differential diagnosis | Trisomy 18, Smith–Lemli–Opitz syndrome |
| Prevention | N/A |
| Treatment | Supportive care |
| Medication | N/A |
| Prognosis | Poor, often results in early childhood death |
| Frequency | Rare, more common in Hutterite communities |
| Deaths | N/A |
Bowen–Conradi syndrome is a rare genetic disorder that is primarily characterized by growth retardation, intellectual disability, and distinctive facial features. It is most commonly found in the Hutterite population, a group of Anabaptists who live in North America.
Symptoms and Signs[edit]
The symptoms of Bowen-Conradi syndrome typically become apparent shortly after birth. These may include:
- Growth retardation
- Intellectual disability
- Distinctive facial features such as a small head (microcephaly), a prominent nose, and a small lower jaw (micrognathia)
- Other physical abnormalities such as short stature, skeletal abnormalities, and heart defects
Causes[edit]
Bowen-Conradi syndrome is caused by mutations in the EMC1 gene. This gene provides instructions for making a protein that is involved in the normal functioning of the endoplasmic reticulum, a structure within cells that is involved in protein processing and transport.
Diagnosis[edit]
Diagnosis of Bowen-Conradi syndrome is based on the presence of characteristic clinical features. Genetic testing can confirm the diagnosis.
Treatment[edit]
There is currently no cure for Bowen-Conradi syndrome. Treatment is supportive and based on the signs and symptoms present in each individual.
Prognosis[edit]
The prognosis for individuals with Bowen-Conradi syndrome is poor. Most affected individuals do not survive past infancy due to the severe health problems associated with this condition.
See Also[edit]
References[edit]
<references />
External Links[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


